Literature DB >> 6834112

Diagnosis and management of pineal tumors.

R Jooma, B E Kendall.   

Abstract

The management of pineal region tumors remains controversial. Advocates of a conservative approach emphasize the excellent results of radiotherapy, particularly with germinomas, while a number of recent reports have demonstrated the safety of direct surgery. In order to improve treatment planning, attempts have been made to distinguish the various tumor types by computerized tomography (CT) and by the use of markers for germ-cell tumors. This paper reports a study of 35 patients with pineal tumors including two ectopic germinomas. Pretreatment CT was performed in all 35 patients, and human chorionic gonadotropin and alpha-fetoprotein levels were assayed in 11. Histological verification was available for 33 tumors; the other two were characterized by clinical and CT features plus tumor markers. Of the 27 tumor operations, 21 were for a pineal mass and six for ectopic germinoma or metastasis. There was no operative mortality. Morbidity was minimal, and surgery did not increase the incidence of subarachnoid seeding. Each histological type of tumor has a typical appearance on CT scanning, although, in the individual case, a firm diagnosis is not always possible. However, consideration of CT scans together with the clinical features, cerebrospinal fluid cytology, tumor markers, and (if there is still doubt) response to a small dose of irradiation will generally allow a specific diagnosis with a high degree of probability. In this way, germinomas may be selected for radiotherapy and the tumors less likely to respond may be subjected to primary surgery.

Entities:  

Mesh:

Year:  1983        PMID: 6834112     DOI: 10.3171/jns.1983.58.5.0654

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

Review 1.  Surgical approaches to pineal region tumors.

Authors:  K M Little; A H Friedman; T Fukushima
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Imaging in the trilateral retinoblastoma syndrome.

Authors:  L J Bagley; R W Hurst; R A Zimmerman; J A Shields; C L Shields; P De Potter
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

3.  Pathobiology of intracranial germ-cell tumors: immunochemical, immunohistochemical, and electron microscopic investigations.

Authors:  H K Inoue; H Naganuma; N Ono
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Pineal parenchymal tumors. Management with interstitial iodine-125 radiosurgery.

Authors:  Mohammad Maarouf; Faycal El Majdoub; Christian Bührle; Jürgen Voges; Ralph Lehrke; Martin Kocher; Stefan Hunsche; Harald Treuer; Volker Sturm
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

Review 5.  Fully endoscopic resection of pineal region tumors.

Authors:  Hrayr Shahinian; Yoon Ra
Journal:  J Neurol Surg B Skull Base       Date:  2013-03-22

6.  Spinal metastasis from occult intracranial germinoma mimicking primary intramedullary tumour.

Authors:  Y Shibamoto; R Asato; M Abe
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

7.  Computed tomography of germinomas in basal ganglia and thalamus.

Authors:  T Soejima; I Takeshita; H Yamamoto; Y Tsukamoto; M Fukui; S Matsuoka
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

8.  Pineal germinoma: diagnosis, treatment and tumor response.

Authors:  S Ferla; S Spartà; R Giordano; P L Zorat; G Marin; G Meneghetti
Journal:  Ital J Neurol Sci       Date:  1987-06

9.  CT and MRI features of intracranial germ cell tumors.

Authors:  T Fujimaki; M Matsutani; N Funada; T Kirino; K Takakura; O Nakamura; A Tamura; K Sano
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

10.  Factors influencing overall survival rates for patients with pineocytoma.

Authors:  Aaron J Clark; Michael E Sughrue; Michael E Ivan; Derick Aranda; Martin J Rutkowski; Ari J Kane; Susan Chang; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-05-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.